Announce of Investment in TBMC, Taiwan. CBC is the authorized distributor in Japan | News | CBC Co.,ltd.
Summary
CBC Group invested in Taiwan Bio-Manufacturing Corporation and signed a memorandum to serve as TBMC’s authorized agent in Japan. The agreement covers TBMC products for cell therapy, gene therapy, nucleic acids, vaccines, and biologics. TBMC plans to expand its bioprocessing footprint in Japan while scaling operations from its sites in Taipei and Hsinchu. The company says its facilities will support complex medicine production and GMP manufacturing by 2025.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected